Discovery of potent Covid‐19 main protease inhibitors using integrated drug‐repurposing strategy

Podobne zapisy

• Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2
  od: Shode, F. O., i wsp.
  Wydane: (2021)
• An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease
  od: Djokovic, Nemanja, i wsp.
  Wydane: (2021)
• Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
  od: Kai S. Yang, i wsp.
  Wydane: (2022-01-01)
• Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)
  od: Khan, Abbas, i wsp.
  Wydane: (2020)
• Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
  od: Fiorucci, Diego, i wsp.
  Wydane: (2020)